In our May issue:
FEATURED
Implementing RBM and RBQM
Mary Banach, Nimita Limaye, Steve Young, Teresa Ancukiewicz, Stephen Wilson, Johann Proeve
Authors present a practical roadmap for clinical study teams implementing or preparing to implement RBM and risk-based quality management (RBQM) approaches—and outline the importance of applying change management techniques throughout the preparation, planning, and execution stages.
Overcoming R&D Bottlenecks
Christian Rack
Though the type of work varies, each department responsible for researching and developing a new drug product has to balance out its workload against the capacities available for the targeted period. To help minimize potential conflicts between the two, this report provides a resource planning and scheduling model, using the example of an analytical department in drug development.
|
NEWS
Washington Report: Jill Wechsler chronicles recent efforts by FDA leaders to urge for increased adoption of streamlined clinical research practices.
EU Report: Peter O'Donnell on the concern over potential election-driven overpromising in Europe's fight against cancer.
Q&A: How one small biopharma company is de-risking its approach in cancer drug development by leveraging strategic partnerships and testing combination regimens.
|
CLOSING THOUGHT
The Behavior Science Solution
Michelle Keefe
As an industry, we need to start employing evidence-based strategies–combining data and behavior science insights–to help patients make better-informed decisions in their healthcare journey, such as exploring a clinical trial.
|
|
|
If you would like to submit an article to Applied Clinical Trials, contact Lisa Henderson, Editorial Director - lhenderson@mmhgroup.com
Applied Clinical Trials is free to qualified subscribers. To subscribe, click here.
Click here to contact the Applied Clinical Trials sales team. |
